Alfonso Quintas Cardama

Companies

• Foghorn Therapeutics Inc.Chief Medical Officer Sep 13, 2023 to now¹
• TCR2 THERAPEUTICS INC.Chief Medical Officer Feb 13, 2019 to Jun 1, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTCR2 THERAPEUTICS INC.0 shares³Jun 1, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 1, 2023Returned to company 109,459 shares of TCR2 THERAPEUTICS INC.³
• Dec 13, 2022Sold 4,752 shares at $1.06 of TCR2 THERAPEUTICS INC.⁴
• Dec 12, 2022Sold 4,586 shares at $1.10 of TCR2 THERAPEUTICS INC.⁴
• Dec 9, 2022Sold 4,461 shares at $1.13 of TCR2 THERAPEUTICS INC.⁴
• Dec 8, 2022Sold 4,014 shares at $1.26 of TCR2 THERAPEUTICS INC.⁵
• Dec 7, 2022Sold 3,928 shares at $1.28 of TCR2 THERAPEUTICS INC.⁵
• Dec 6, 2022Sold 3,778 shares at $1.33 of TCR2 THERAPEUTICS INC.⁶
• Dec 5, 2022Sold 3,686 shares at $1.37 of TCR2 THERAPEUTICS INC.⁶
• Dec 2, 2022Sold 3,636 shares at $1.39 of TCR2 THERAPEUTICS INC.⁷
• Dec 1, 2022Exercised options 95,385 shares of TCR2 THERAPEUTICS INC.⁷
• Dec 9, 2021Exercised options 43,000 shares at $0.74 of TCR2 THERAPEUTICS INC.⁸
• Aug 31, 2021Granted 164 shares at $14.26 of TCR2 THERAPEUTICS INC.⁸